https://www.selleckchem.com/pr....oducts/poziotinib-hm
Background High out-of-pocket costs (OOPCs) often are found to be inversely associated with adherence to medical treatment. The introduction of generic aromatase inhibitors (GAIs) significantly reduced the OOPCs of patients. The objective of the current study was to explore the impact of the introduction of GAIs on adjuvant hormone therapy (AHT) adherence over the full course of breast cancer treatment. Methods Women aged ≥65 years who were diagnosed with hormone receptor-positive breast cancer from 2007 through mid-2009 we
Like
Comment
Share
